A phase 3 trial found that Eli Lilly's tirzepatide significantly reduced the risk of progression to Type 2 diabetes in prediabetic adults over a three-year period. Nearly 99% of individuals treated ...
While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...
With new weight-loss drugs hailed as ‘miracle’ medicines, Harriet Symonds explores whether their increasing popularity should ...
The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...
After a nurse died after just two weight-loss injections of Mounjaro - which is approved for use on the NHS - here's ...
Jim Gaffigan reveals his weight loss journey with Mounjaro tackling food addiction and societal stigma while balancing comedy ...
Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...
Following an impressive data drop this summer highlighting the potential for Eli Lilly’s tirzepatide to stave off progression ...
Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...
Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...
The popularity of weight loss drugs such as Ozempic and Mounjaro continue to reflect Americans' desire to slim down. While ...
Jim Gaffigan has always used his weight and love for eating as a punchline in his comedy, even going so far to title his 2013 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback